CD8A and neoplasm: Of note, the percentage of either Granzyme B-positive or IFN-γ-positive CD8+T cells was also significantly potentiated (Fig. 6G), suggesting the enhanced anti-tumor capacity of CD8+T cells after the combined treatment.